187 related articles for article (PubMed ID: 11799838)
1. Animal models of chronic obstructive pulmonary disease.
Szelenyi I; Marx D
Arzneimittelforschung; 2001; 51(12):1004-14. PubMed ID: 11799838
[TBL] [Abstract][Full Text] [Related]
2. COPD: a multifactorial systemic disease.
Huertas A; Palange P
Ther Adv Respir Dis; 2011 Jun; 5(3):217-24. PubMed ID: 21429981
[TBL] [Abstract][Full Text] [Related]
3. Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation.
Birrell MA; Wong S; Hele DJ; McCluskie K; Hardaker E; Belvisi MG
Am J Respir Crit Care Med; 2005 Jul; 172(1):74-84. PubMed ID: 15805185
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease.
Pietila MP; Thomas CF
Semin Respir Infect; 2003 Mar; 18(1):9-16. PubMed ID: 12652449
[TBL] [Abstract][Full Text] [Related]
5. Chronic obstructive pulmonary disease in a new concept.
Murărescu ED; Mitrofan EC; Mihailovici MS
Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487
[TBL] [Abstract][Full Text] [Related]
6. Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?
Churg A; Sin DD; Wright JL
Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1111-5. PubMed ID: 21685155
[TBL] [Abstract][Full Text] [Related]
7. The pathogenesis of COPD: lessons learned from in vivo animal models.
Fujita M; Nakanishi Y
Med Sci Monit; 2007 Feb; 13(2):RA19-24. PubMed ID: 17261992
[TBL] [Abstract][Full Text] [Related]
8. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD).
MacNee W
Biochem Soc Trans; 2009 Aug; 37(Pt 4):819-23. PubMed ID: 19614601
[TBL] [Abstract][Full Text] [Related]
9. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease.
Wright JL; Churg A
Expert Rev Respir Med; 2010 Dec; 4(6):723-34. PubMed ID: 21128748
[TBL] [Abstract][Full Text] [Related]
10. Experimental COPD induced by solid combustible burn smoke in rats: a study of the emphysematous changes of the pulmonary parenchyma.
Murărescu ED; Eloae-Zugun F; Mihailovici MS
Rom J Morphol Embryol; 2008; 49(4):495-505. PubMed ID: 19050798
[TBL] [Abstract][Full Text] [Related]
11. [Living conditions for people with COPD].
Hem KG; Eide AH
Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1465-8. PubMed ID: 19690596
[TBL] [Abstract][Full Text] [Related]
12. Aspects on pathophysiological mechanisms in COPD.
Larsson K
J Intern Med; 2007 Sep; 262(3):311-40. PubMed ID: 17697154
[TBL] [Abstract][Full Text] [Related]
13. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance.
Stevenson CS; Birrell MA
Pharmacol Ther; 2011 May; 130(2):93-105. PubMed ID: 21074553
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM
Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045
[TBL] [Abstract][Full Text] [Related]
15. The aging lung and chronic obstructive pulmonary disease: similarity and difference.
Fukuchi Y
Proc Am Thorac Soc; 2009 Dec; 6(7):570-2. PubMed ID: 19934351
[TBL] [Abstract][Full Text] [Related]
16. The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD.
Fox JC; Fitzgerald MF
Curr Opin Pharmacol; 2009 Jun; 9(3):231-42. PubMed ID: 19356979
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
18. [Pathomechanisms in chronic obstructive pulmonary disease (COPD)].
Glaab T; Hohlfeld JM; Jörres RA; Krug N; Welte T
Med Klin (Munich); 2006 Dec; 101(12):951-6. PubMed ID: 17171318
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of the chronic obstructive pulmonary disease (COPD)].
Musil J
Vnitr Lek; 2004 Sep; 50(9):663-7. PubMed ID: 15580897
[TBL] [Abstract][Full Text] [Related]
20. Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?
Zhang WH; Zhang Y; Cui YY; Rong WF; Cambier C; Devillier P; Bureau F; Advenier C; Gustin P
Fundam Clin Pharmacol; 2012 Feb; 26(1):118-34. PubMed ID: 22044554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
